AVBP vs ETN · $1.39B cap vs P/E 39, rev $15.98B
ArriVent BioPharma, Inc. Common Stock (AVBP) versus Eaton Corporation PLC (ETN) — a side-by-side from cached financials, not a winner call.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
AVBP does not have a complete income-statement cache yet.
Latest reported ETN revenue for 2026-06-30 was $15.98B. Net income was $1.69B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
AVBP currently screens at market cap $1.39B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Not investment advice. Open the AVBP and ETN stock pages for the full models.
Not investment advice.